Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 37.16 | 0.73% | 0.27 |
SBIO closed up 0.73 percent on Wednesday, November 20, 2024, on 1.89 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 0.73% | |
| Gapped Down | Weakness | 0.73% | |
| Oversold Stochastic | Weakness | 0.73% | |
| Stochastic Reached Oversold | Weakness | 2.04% | |
| Down 3 Days in a Row | Weakness | 2.04% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 22 hours ago |
| 1.5x Volume Pace | about 22 hours ago |
| 3x Volume Pace | about 22 hours ago |
| 5x Volume Pace | about 22 hours ago |
| 60 Minute Opening Range Breakout | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 42.73 |
| 52 Week Low | 24.9915 |
| Average Volume | 8,401 |
| 200-Day Moving Average | 35.83 |
| 50-Day Moving Average | 38.42 |
| 20-Day Moving Average | 39.06 |
| 10-Day Moving Average | 39.32 |
| Average True Range | 0.92 |
| RSI (14) | 41.18 |
| ADX | 21.87 |
| +DI | 25.42 |
| -DI | 42.43 |
| Chandelier Exit (Long, 3 ATRs) | 39.96 |
| Chandelier Exit (Short, 3 ATRs) | 38.89 |
| Upper Bollinger Bands | 42.42 |
| Lower Bollinger Band | 35.70 |
| Percent B (%b) | 0.22 |
| BandWidth | 17.20 |
| MACD Line | -0.22 |
| MACD Signal Line | 0.26 |
| MACD Histogram | -0.4765 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 38.11 | ||||
| Resistance 3 (R3) | 38.02 | 37.61 | 37.96 | ||
| Resistance 2 (R2) | 37.61 | 37.37 | 37.66 | 37.90 | |
| Resistance 1 (R1) | 37.39 | 37.22 | 37.50 | 37.48 | 37.85 |
| Pivot Point | 36.98 | 36.98 | 37.03 | 37.02 | 36.98 |
| Support 1 (S1) | 36.75 | 36.73 | 36.86 | 36.84 | 36.47 |
| Support 2 (S2) | 36.34 | 36.58 | 36.39 | 36.42 | |
| Support 3 (S3) | 36.12 | 36.34 | 36.37 | ||
| Support 4 (S4) | 36.21 |
